Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal changes in the macular, resulting in reduced vision and distorted objects.
Patent for methods of use of topical DNase enzymes in the eye covers L304, Neutrolis’ proprietary therapy in development for the treatment of moderate to severe dry eye disease CAMBRIDGE, Mass., Dec.
A digital therapeutic (DTx) for amblyopia – sometimes known as lazy eye – has been shown to improve vision correction over standard therapy in a phase 3 trial, according to its developer ...
NEW DELHI (Reuters) – Rishabh Pant and Shreyas Iyer bagged eye-watering $3 million-plus deals in Sunday’s Indian Premier League (IPL) auction shattering the previous payment record in the ...
A non-inferiority trial, similar in methodology to the Cornell University study, found no differences in dry cow treatments. This study, conducted by the University of Minnesota, the University of ...
Opens in a new tab or window Patients with Leber hereditary optic neuropathy (LHON) due to the MT-ND4 gene variant treated with the gene therapy lenadogene nolparvovec in one eye showed a ...
Mumbai Indians (MI) have the knack for unearthing best talents from all around the globe and they might have struck the right nerve once again. The joint-most successful Indian Premier League (IPL) ...
He then led previous IPL franchise Kolkata Knight Riders to their third Indian Premier League title. He was also a member of the Irani Cup-winning Mumbai team. He was acquired by Punjab Kings for ...
Sep. 9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million ...